doi: 10.1016/s0092-8674(03)00154-5
Disclosures: Manasa Ginjupalli: Nothing to Disclose, Anuj Sharma: Nothing to Disclose, Fnu Vikash: Nothing to Disclose, Vikash Kumar: Nothing to Disclose, Gautam Maddineni: Nothing to Disclose, Arnold Nongmoh Forlemu: Nothing to Disclose, Jayalekshmi Jayakumar: Nothing to Disclose, Camelia Ciobanu: Nothing to Disclose, Ali Wakil: Nothing to Disclose, Amr Dokmak: Nothing to Disclose, Vijay Bhaskar Reddy Gayam: Nothing to Disclose, Praneeth Bandaru: Nothing to Disclose, Khalid Aloum: Nothing to Disclose, Raissa Nana Sede Mbakop: Nothing to Disclose, Lisnaldy Ramirez: Nothing to Disclose, Denzil Etienne: Nothing to Disclose, Madhavi Reddy: Nothing to Disclose 1913 MUTATED-Β- CATENIN DRIVES SUPPRESSION OF AN IMMUNE-REGULATORY MODULE OF TRANSCRIPTION FACTORS ALTERING EXPRESSION OF KEY CHEMOKINES INVOLVED IN IMMUNE RESPONSE IN HEPATOCELLULAR CANCERS Brandon Lehrich 1 Junyan Tao 1 Evan Delgado 1 Catherine Cao 1 Tyler Yasaka 1 Yuqing Liu 1 Minakshi Poddar 1 Sucha Singh 1 Xiangnan Guan 2 Hartmut Koeppen 2 Silvia Liu 1 Yulei Wang 2 Satdarshan (Paul) Monga 1 , 1 University of Pittsburgh, 2 Translational Medicine, Genentech Inc., San Francisco, CA, USA Background: Hepatocellular carcinoma (HCC) is the third-leading cause of cancer-related mortality worldwide
Side effects can vary based on dose, frequency, product quality, medical history, medications, and individual response
As newly identified metal ion-dependent programmed cell death modalities, ferroptosis and cuproptosis play critical roles in tumor metabolism, immune microenvironment remodeling, and therapeutic resistance, representing emerging research foci in OSCC
